Outset Medical (OM) Cash from Operations Growth (1y) (2020 - 2026)
Outset Medical (OM) Cash from Operations Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.33 Bn | 174.04 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 128.11 Bn | 125.23 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 107.76 Bn | 98.54 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 67.95 Bn | 66.50 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | -84.38% |
| 6 | GE HealthCare Technologies | 28.43 Bn | 26.14 Bn | 1.98 Bn | 16.00% |
| 7 | Dexcom | 28.31 Bn | 27.20 Bn | 750.30 Mn | 185.96% |
| 8 | Smith & Nephew | 26.77 Bn | 26.19 Bn | - | - |
| 9 | Koninklijke Philips | 25.33 Bn | 22.21 Bn | 2.07 Bn | 122.43% |
| 10 | Outset Medical | 75,880.49 | -286.57 Mn | 12.10 Mn | 49.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.95% |
| Dec 31, 2025 | 42.25% |
| Sep 30, 2025 | 69.27% |
| Jun 30, 2025 | 85.53% |
| Mar 31, 2025 | 44.10% |
| Dec 31, 2024 | 32.54% |
| Sep 30, 2024 | 39.50% |
| Jun 30, 2024 | -18.31% |
| Mar 31, 2024 | -2.58% |
| Dec 31, 2023 | 29.17% |
| Sep 30, 2023 | 0.91% |
| Jun 30, 2023 | 26.96% |
| Mar 31, 2023 | -16.75% |
| Dec 31, 2022 | -5.60% |
| Sep 30, 2022 | -21.97% |
| Jun 30, 2022 | -25.08% |
| Mar 31, 2022 | 0.73% |
| Dec 31, 2021 | -26.46% |
| Sep 30, 2021 | 3.38% |
| Jun 30, 2021 | -60.92% |